Papers authored by Melanoma Study Group Of The Mayo Clinic Cancer CenteR

Collect these papers and discover other ones on Labmeeting. Learn more.
Evidence of systemic Th2-driven chronic inflammation in patients with metastatic melanoma.
+ cite this
+ View Abstract
Nevala WK, Vachon CM, Leontovich AA, Scott CG, Thompson MA, Markovic SN, and Melanoma Study Group of the Mayo Clinic Cancer Center
Clinical cancer research : an official journal of the American Association for Cancer Research 15(6):1931-9, 2009 Mar 15 - Who cited this? | PubMed ID: 19240164 | Fulltext
Recommend
Overlapping human leukocyte antigen class I/II binding peptide vaccine for the treatment of patients with stage IV melanoma: evidence of systemic immune dysfunction.
+ cite this
+ View Abstract
Melanoma Study Group of the Mayo Clinic Cancer Center and Celis E
Cancer 110(1):203-14, 2007 Jul 1 - Who cited this? | PubMed ID: 17541944 | Fulltext
Recommend
Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis.
+ cite this
+ View Abstract
Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, Vachon CM, Schild SE, McWilliams RR, Hand JL, Laman SD, Kottschade LA, Maples WJ, Pittelkow MR, Pulido JS, Cameron JD, 
 (show remaining authors)
Mayo Clinic proceedings. Mayo Clinic 82(3):364-80, 2007 Mar - Who cited this? | PubMed ID: 17352373 | Fulltext
Recommend



Search Google Scholar for Melanoma Study Group Of The Mayo Clinic Cancer CenteR

Join Labmeeting

  • Organize and search your PDF collection
  • Collect papers
  • Search millions of papers
  • Keep up to date with paper alerts
  • Read your papers from anywhere
  • Recommend papers to colleagues
  • Manage your lab
Sign Up

Join Labmeeting

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.


Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!